The main component of this group is the diacyl derivative:
1,2-diacyl-sn-glycero-3-phosphorylcholine or phosphatidylcholine or lecithin.

R1 and R2 are identical or different fatty acids
Phosphatidylcholine is abundant in all cell extracts, it frequently forms
about half of all membrane phospholipids in animal preparations. In animal cells, the
fatty acid from the 1-position is frequently 16:0 and that from the 2-position is 18:1 or
18:2, exceptionally more unsaturated fatty acids are found. Choline has a pK near 13.9 and
produces a polar head group with a strong zwitterionic character over the entire pH range.
While the diacyl form is the most abundant, other forms can be found in cell extracts.
A graphical chart of the biosynthesis of phosphatidylcholine may be found on the
BioCarta
web site.
After the first observations of diacylglycerol formation by hormone-stimulated
hepatocytes (Hughes
BP et al., Biochem J 1984, 222, 535; Bocckino
SB et al., J Biol Chem 1985, 260, 14201), it became progressively
evident that phosphatidylcholine plays an important and general role in cell
signalling. The first unambiguous demonstration was that of a rapid formation of
diacylglycerol from phosphatidylcholine in stimulated pre-adipocytic 3T3 cell
line (Besterman
JM et al., PNAS 1986, 83, 6785). Various signal transduction systems
have been investigated and have demonstrated that in endothelin-1 stimulated
vessels (Liu
GL et al., J Vasc Res 1999, 36, 35), in PDGF-induced activation of MAPK
pathway in fibroblasts (Van
Dijk MC et al., J Biol Chem 1997, 272, 11011), in thyroxine stimulation
of liver cells (Kavok
NS et al., BMC cell Biol 2001, 2:5) and in prostaglandin-induced
proliferation of osteoblasts (Sakai
T et al., J Bone Miner Metab 2004, 22, 198), a production of
diacylglycerol species from phosphatidylcholine is generated.
A novel family of oxidized phosphatidylcholine was shown to serve as ligands for
the macrophage scavenger receptor CD36 (Podrez
EA et al., J Biol Chem 2002, 277, 38503). These structures were shown to
derived from phosphatidylcholine molecules having C16:0 at the sn-1 position and
either C18:2n-6, C20:4n-6 or C22:6n-3 at the sn-2 position. Thus, the active species on
CD36 have been identified to have an sn-2 acyl group that incorporates a
terminal g-hydroxy
(or oxo)-a,b-unsaturated
carbonyl (alcohol or aldehyde group). As an example, the species shown below is
generated from oxidation of a docosahexaenoic acid ester. The compounds
generated from different precursors are similar except for the chain length of
the truncated oxidized fatty acid at the sn-2 position.
These oxidized phosphatidylcholine
species are likely involved in the CD36-mediated recognition of oxidized
lipoproteins and foam cell formation in vivo. It has been suggested that
they may be also potential targets for antimicrobial peptides (Mattila
JP et al., Biochim Biophys Acta 2008, 1778, 2041).
Oxidized phospholipids
are the result of a series of radical catalyzed chemical reactions
and display physiopathological roles in disease development
as in age-related and chronic diseases, atherosclerosis, inflammation, immune
responses and various neurodegenerative diseases. Evidence is progressively growing that oxidized
phosphatidylcholines are potent agonist for peroxisome proliferator-activated
receptor gamma (review in : Konger
RL et al., Prost Lipid Med 2008, 87, 1). Oxidized
phosphatidylcholine can initiate and modulate many cellular events linked to
inflammation and atherosclerosis. As they may be accumulated in vivo,
suggestions have been made that they could be biomarkers reflecting these
diseases (Ashraf
MZ et al., Int J Biochem Cell Biol 2009, 41, 1241). A spectrometry
technique has been developed for the determination of several species of
oxidized phosphatidylcholine generated in a myocardium ischemia-reperfusion
model (Nakanishi
H et al., J Chromatogr B 2009, 877, 1366).
A review of the nature, biological activities and analysis of
phosphatidylcholine and other phospholipids may be consulted (Domingues
MR et al., Chem Phys Lipids 2008, 156, 1).
It was shown that a phosphatidylcholine species with esterified sn-2-azelaidic
acid was the most common phospholipid oxidation product of oxidized low density
lipoprotein (Tokumura
A et al., Lipids 1996, 31, 1251). It is noteworthy that oxidized LDL
levels in carotid plaque are 70-fold greater than circulating levels (Nishi
K et al., Artherioscler Thromb Vasc Biol 2002, 22, 1649).
It was further demonstrated
that these phospholipid oxidation products target intracellular mitochondria to
activate the intrinsic apoptotic cascade (Chen
R et al., J Biol Chem 2007, 282, 24842).
It was later shown that molecular species possessing a fatty acyl hydroxyalkenal
group can undergo a slow transformation into a novel oxidized species with a
sn-2 acyl group incorporating a terminal furan moiety (Gao
S et al., J Biol Chem 2006, 281, 31298). One of these species is shown
below.
These derivatives
were shown to be generated at sites of enhanced oxidant stress, such as within
brain tissues. This was the first reported description of furan-containing
phospholipids as endogenous products in a mammalian system. In contrast to their
hydroxyalkenal precursors, these furan derivatives lack CD36 binding activity.
The alk-1-enyl-acyl derivatives (1-alk-1'-enyl-,
2-acyl-sn-glycero-3-phosphorylcholine) are also named choline plasmalogen.
As the first carbon of glycerol is linked to the carbon chain through a -C-O-C=C- vinyl
ether bond, these lipids are known as ether-linked lipids or ether lipids.
The vinyl ether bond is acid labile. This form is present in appreciable quantity in some
tissues as heart muscle (up to 40% of choline glycerophospholipids), in seminal fluid, and
in smaller amounts in nervous system, platelets or red blood cells. The presence of this
type of lipid was detected around 1930 by Feulgen in histological sections where a
positive reaction with the fuchsine-sulfurous acid reagent was observed in the cellular
cytoplasm. The detected aldehyde was formed from the broken vinyl ether bond, the rest of
the molecule giving a lyso-phospholipid (1-lyso 2-acyl phospholipid). This reaction was
mainly due to the more abundant ethanolamine plasmalogen. Choline
plasmalogen was the first aldehydogenic lipid to be isolated in a pure form (Gottfried et
al., Fed Proc , 1961, 20, 278).
The
first carbon chain is of the vinyl ether group, n being usually equal to 13-15. The second
carbon chain is an esterified fatty acid with x being equal to 14-16 and possibly with one
or two double bonds.
In plasmalogens from sheep heart, it was shown that the alkenyl chains are
mainly composed of 16:0, 18:0, and 18:1n-3 but also of several trans isomers of
18:1. The t11-18:1 (vaccenic acid) was the most abundant (about 5%) but several
others have their ethylenic bond spanning from C6-C8 to C16, which were similar
to those isolated from sheep adipose tissue. Furthermore, several trans-16:1
alkenyl chains could be observed (ca. 1%), cis-16:1 isomers being present in
trace amounts (Wolff
RL, Lipids 2002, 37, 811)
The vinyl ether bond is very sensitive to acid treatment which generates a free long-chain
aldehyde. When the acid treatment is made in the presence of methanol, it generates
dimethyl acetals.
These derivatives are stable, they can be purified and analyzed by gas liquid
chromatography.
The physiological function of these compounds remains poorly known. It was
reported that thrombin treatment of endothelial cells activates a selective
hydrolysis (phospholipase A2) of choline plasmalogen containing arachidonic acid
in the sn2 position (85% of this phospholipid contain arachidonate) , thus
releasing a lysoplasmenylcholine and a fatty acid leading to eicosanoid
production (Creer MH et al., Am J Physiol 1998, 275, C1498).
A decrease in the biosynthesis of plasmalogens is observed in several peroxisome
biogenesis disorders such as the Zellweger syndrome, the neonatal
adrenoleukodystrophy and some form of chondrodysplasia (Steinberg
SJ et al., Biochim Biophys Acta 2006, 1763, 1733).
The alkyl, acyl derivative
(1-alkyl-,2-acyl-sn-glycero-3-phosphorylcholine) is another ether lipid (saturated ether
type) present in all cells but in low amounts (in general higher than those of choline
plasmalogen). Appreciable quantities (20-50%) occur amongst the choline phospholipids of Tetrahymena,
some mollusks, crustacea and various vertebrate tissues. The ether bond in these lipids is acid
and alkali stable, the complete hydrolysis of the molecule giving 2 types of glycerol
ether: 1-O-hexadecyl-sn-glycerol (chimyl alcohol)
and 1-O-octadecyl-sn-glycerol (batyl alcohol).
The
first carbon chain is of the saturated ether form where n represents 15 or 17, while x is
usually 14 or 16 with one or two double bonds.
An important derivative of this ether lipid is the Platelet Activating Factor (PAF) which is a 1-alkyl-,-2-acetyl-sn-glycero-3-phosphocholine, lipid mediator playing through a specific receptor a role in inflammatory and immune responses, and in platelet aggregation. It was also shown to be present in spermatozoid membrane and to be able to increase their mobility.
This
is the structural formula of PAF where n is 15, or 17, in this case with most frequently
one double bond.
In addition to enzymatically catalyzed PAF production, PAF receptor ligands are
also generated non-enzymatically, and thus not subject to cellular control.
Several derivatives, including PAF itself, may be generated by oxidative
reactions. It has been shown that PAF and analogues are biologically active
mediators for ultraviolet radiation-mediated effects in skin (review in : Konger
RL et al., Prost Lipid Med 2008, 87, 1).
Furthermore, ether glycerophospholipids may have one or two hydrocarbon chains
linked to glycerol by an ether bond (Paltauf F, Chem Phys Lipids 1994, 74,
101).
Ether lipids have been shown to have anti-tumor properties (apoptotic activity), including reduction of tumor cell invasion and inhibition of tumor metastases. Several analogues were synthesized in order to have very low rates of metabolism. Below are shown two very active molecules (edelfosine and ilmofosine) analogous to PAF but lacking the hydrolyzable ester functionality at the sn-2 position.

A number of other analogues were synthesized as they display antitumor activity after being taken up specifically by malignant cells. Fluorescent analogues were also synthesized as they are very useful for unveiling their mechanism of action and therapeutic targets (Quesada E et al., J Med Chem 2004, 47, 5333). The mechanism of inhibition of cell signaling pathways by these antitumor ether lipids has been reviewed (Arthur G et al., Biochim Biophys Acta 1998, 1390, 85).
Monoacyl derivatives (lyso
glycerophosphorylcholine)
This is a minor component (1 to 5%) of the tissue phospholipids. 1-acyl or 2-acyl
derivatives may arise because of the action of specific phospholipases. They are very
polar and have detergent properties.
Here
is shown the 2-lysophosphatidylcholine produced by phospholipase A2 hydrolysis. This
action is intimately associated with the signal transduction pathway in all types of cells
(an unsaturated fatty acid is liberated and may be metabolized in various derivatives by
other enzymes). A phospholipase A1 is able to cleave the sn-1 ester bond and generate a
1-lysocompound. These enzymes are used to study the phospholipid structure.
Lysophosphatidylcholine was also shown to be a selective chemoattractant for
mononuclear leukocytes (Quinn
MT et al., Proc Natl Acad Sci USA 1988, 85, 2805) and to be a
pathological component of oxidized LDL in plasma (Parthasarathy
S et al., Atheriosclerosis 1989, 9, 398) and of atherosclerotic lesions (Portman
OW et al., J Lipid Res 1969, 10, 158).
More recently, it was reported that lysophosphatidylcholine was able to promote
mature dendritic cell generation through G protein-coupled receptors on differentiating monocytes
(Coutant F et al., J Immunol 2002, 169, 1688). This new cell signalling
process opens perspectives for the understanding and treatment of acute and chronic inflammatory diseases.
Sulfonium analog
of phosphatidylcholine
A phosphatidylcholine analog containing a sulfur atom replacing the nitrogen
atom of choline has been described in marine diatoms and algae (Bisseret
P et al., Biochim Biophys Acta 1984, 796, 320). Thus, only two methyl
groups are present at the end of the polar head : - S+(CH3)2
instead of - N+(CH3)3 . Furthermore, this phosphatidylsulfocholine,
discovered in the diatom Nitzschia alba, completely replaces phosphatidylcholine in
this species (Anderson R
et al., Biochim Biophys Acta 1978, 528, 77). Methionine was shown to
supply the S atom as well as both methyl groups of the dimethyl sulfonium moiety
of the molecule.